We're not fully back to that great optimism we had a couple of years ago: Seigerman on pharma sector
Evan Seigerman, managing director at BMO Capital Markets, joins BNN Bloomberg to discuss the impact of U.S.-China relations on Eli Lilly and the pharma sector.